Cannabis stocks – struggling to get high

Cannabis stocks – struggling to get high
Greenfern will soon start writing clinical trial protocols for a low dose cannabidiol medication. (Image: Getty)
Brian Gaynor
The three NZX-listed cannabis companies – Cannasouth, Greenfern Industries and Rua Bioscience – are struggling to gain momentum, particularly as far as their share price performances are concerned.All three stocks are trading well below their issue price.This will be a major disappointment to Sharesies investors because they have dominated trading activity in all three companies.Sharesies investors make up 61% of all Cannasouth on-market trades by number since listing, 70.5% of Greenfern’s trades, and 64.3% of Rua Bioscience&r...

More Opinion

War on the Nasdaq
Opinion

Simon Robertson: War on the Nasdaq

Who wins as Michael Burry declares war on AI?

Simon Robertson 08 Nov 2025
War on Nature v Going for Growth
Opinion

Pattrick Smellie: War on Nature v Going for Growth

Some big environmental eggs were broken this week to 'go for growth'.

Pattrick Smellie 07 Nov 2025
A blueprint to beat our economic malaise
Opinion

Peter Griffin: A blueprint to beat our economic malaise

NZ must trade talk for execution and invest in talent to escape its economic woes. 

Peter Griffin 05 Nov 2025
KiwiSaver: Why side-pockets are out
Opinion

David Chaplin: KiwiSaver: Why side-pockets are out

Government scraps KiwiSaver reforms, keeps only disclosure tweak.

David Chaplin 04 Nov 2025